116 related articles for article (PubMed ID: 20554191)
1. Proteomic analysis of anti-tumor effects by tetrandrine treatment in HepG2 cells.
Cheng Z; Wang K; Wei J; Lu X; Liu B
Phytomedicine; 2010 Nov; 17(13):1000-5. PubMed ID: 20554191
[TBL] [Abstract][Full Text] [Related]
2. Potential role of tetrandrine in cancer therapy.
Chen YJ
Acta Pharmacol Sin; 2002 Dec; 23(12):1102-6. PubMed ID: 12466047
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of anti-tumor effects by Rhizoma Paridis total saponin treatment in HepG2 cells.
Cheng ZX; Liu BR; Qian XP; Ding YT; Hu WJ; Sun J; Yu LX
J Ethnopharmacol; 2008 Nov; 120(2):129-37. PubMed ID: 18761071
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines.
Ng LT; Chiang LC; Lin YT; Lin CC
Am J Chin Med; 2006; 34(1):125-35. PubMed ID: 16437745
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of hepatocellular carcinoma HepG2 cells treated with platycodin D.
Lu JJ; Lu DZ; Chen YF; Dong YT; Zhang JR; Li T; Tang ZH; Yang Z
Chin J Nat Med; 2015 Sep; 13(9):673-9. PubMed ID: 26412427
[TBL] [Abstract][Full Text] [Related]
6. Tetrandrine selectively protects against amyloid-beta protein - but not against MPTP-induced cytotoxicity in SK-N-SH neuroblastoma cells.
Chiou WF; Lee WS; Yeh PH
Planta Med; 2006 Nov; 72(14):1300-4. PubMed ID: 17051460
[TBL] [Abstract][Full Text] [Related]
7. Proteomic identification of proteins involved in the anticancer activities of oridonin in HepG2 cells.
Wang H; Ye Y; Pan SY; Zhu GY; Li YW; Fong DW; Yu ZL
Phytomedicine; 2011 Jan; 18(2-3):163-9. PubMed ID: 20724128
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of antibacterial activity of tetrandrine against Staphylococcus aureus.
Lee YS; Han SH; Lee SH; Kim YG; Park CB; Kang OH; Keum JH; Kim SB; Mun SH; Seo YS; Myung NY; Kwon DY
Foodborne Pathog Dis; 2012 Aug; 9(8):686-91. PubMed ID: 22845553
[TBL] [Abstract][Full Text] [Related]
9. Effects of tetrandrine plus radiation on neuroblastoma cells.
Chen Y; Chen JC; Tseng SH
Anticancer Res; 2009 Aug; 29(8):3163-71. PubMed ID: 19661330
[TBL] [Abstract][Full Text] [Related]
10. Synergistic anti-candidal activity of tetrandrine on ketoconazole: an experimental study.
Zhang H; Wang K; Zhang G; Ho HI; Gao A
Planta Med; 2010 Jan; 76(1):53-61. PubMed ID: 19644794
[TBL] [Abstract][Full Text] [Related]
11. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
[TBL] [Abstract][Full Text] [Related]
12. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
Fu L; Liang Y; Deng L; Ding Y; Chen L; Ye Y; Yang X; Pan Q
Cancer Chemother Pharmacol; 2004 Apr; 53(4):349-56. PubMed ID: 14666379
[TBL] [Abstract][Full Text] [Related]
13. Effects of tetrandrine on glioma cell malignant phenotype via inhibition of ADAM17.
Wu Z; Wang G; Xu S; Li Y; Tian Y; Niu H; Yuan F; Zhou F; Hao Z; Zheng Y; Li Q; Wang J
Tumour Biol; 2014 Mar; 35(3):2205-10. PubMed ID: 24185966
[TBL] [Abstract][Full Text] [Related]
14. Reduction of doxorubicin resistance by tetrandrine and dauricine in harringtonine-resistant human leukemia (HL60) cells.
He QY; Meng FH; Zhang HQ
Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):179-81. PubMed ID: 9772674
[TBL] [Abstract][Full Text] [Related]
15. Tetrandrine protects mice from concanavalin A-induced hepatitis through inhibiting NF-kappaB activation.
Feng D; Mei Y; Wang Y; Zhang B; Wang C; Xu L
Immunol Lett; 2008 Dec; 121(2):127-33. PubMed ID: 18992279
[TBL] [Abstract][Full Text] [Related]
16. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis.
Hsu YC; Chiu YT; Cheng CC; Wu CF; Lin YL; Huang YT
J Gastroenterol Hepatol; 2007 Jan; 22(1):99-111. PubMed ID: 17201889
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of proteins secreted by HepG2 cells treated with butyl benzyl phthalate.
Choi S; Park SY; Kwak D; Phark S; Lee M; Lim JY; Jung WW; Sul D
J Toxicol Environ Health A; 2010; 73(21-22):1570-85. PubMed ID: 20954082
[TBL] [Abstract][Full Text] [Related]
18. [The study of anti-tumor effect of Tetrandrine combined with Nedaplatin on human liver cancer cell line 7402].
Deng WY; Luo SX; Zhou MQ; Li N; Chen XB; Han LL
Zhong Yao Cai; 2008 Oct; 31(10):1522-5. PubMed ID: 19230406
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines.
Wei J; Liu B; Wang L; Qian X; Ding Y; Yu L
Cancer Chemother Pharmacol; 2007 Oct; 60(5):703-11. PubMed ID: 17256130
[TBL] [Abstract][Full Text] [Related]
20. Comparative proteomics analysis of the proteins associated with laryngeal carcinoma-related gene 1.
Zhang X; Xiao Z; Chen Z; Li C; Li J; Yanhui Y; Yang F; Yang Y; Oyang Y
Laryngoscope; 2006 Feb; 116(2):224-30. PubMed ID: 16467709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
